| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 17/01/2025 | 22:11 | Edgar (US Regulatory) | Form S-4/A - Registration of securities, business combinations: [Amend] | NASDAQ:ALVR | AlloVir Inc |
| 15/01/2025 | 22:41 | Edgar (US Regulatory) | Form 425 - Prospectuses and communications, business combinations | NASDAQ:ALVR | AlloVir Inc |
| 15/01/2025 | 22:39 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:ALVR | AlloVir Inc |
| 09/12/2024 | 12:37 | Edgar (US Regulatory) | Form S-4 - Registration of securities, business combinations | NASDAQ:ALVR | AlloVir Inc |
| 06/12/2024 | 13:23 | Edgar (US Regulatory) | Form DEF 14A - Other definitive proxy statements | NASDAQ:ALVR | AlloVir Inc |
| 26/11/2024 | 22:33 | Edgar (US Regulatory) | Form PRE 14A - Other preliminary proxy statements | NASDAQ:ALVR | AlloVir Inc |
| 20/11/2024 | 22:15 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:ALVR | AlloVir Inc |
| 20/11/2024 | 02:00 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:ALVR | AlloVir Inc |
| 11/10/2024 | 22:02 | Edgar (US Regulatory) | Form SC 13G - Statement of Beneficial Ownership by Certain Investors | NASDAQ:ALVR | AlloVir Inc |
| 09/08/2024 | 15:05 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:ALVR | AlloVir Inc |
| 03/08/2024 | 00:25 | Edgar (US Regulatory) | Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] | NASDAQ:ALVR | AlloVir Inc |
| 14/03/2024 | 11:10 | PR Newswire (US) | Class Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law Firm | NASDAQ:ALVR | AlloVir Inc |
| 07/03/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVR | NASDAQ:ALVR | AlloVir Inc |
| 15/02/2024 | 22:30 | Edgar (US Regulatory) | Form RW - Registration Withdrawal Request | NASDAQ:ALVR | AlloVir Inc |
| 09/02/2024 | 11:45 | PR Newswire (US) | Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class Action - Contact The Gross Law Firm to Learn More | NASDAQ:ALVR | AlloVir Inc |
| 02/02/2024 | 11:45 | PR Newswire (US) | SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024 - (NASDAQ: ALVR) | NASDAQ:ALVR | AlloVir Inc |
| 09/01/2024 | 18:32 | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:ALVR | AlloVir Inc |
| 09/01/2024 | 18:29 | Edgar (US Regulatory) | Form SC 13G - Statement of acquisition of beneficial ownership by individuals | NASDAQ:ALVR | AlloVir Inc |
| 05/01/2024 | 12:14 | IH Market News | Wall Street Highlights: Google Rejects Union Negotiations, Exxon Mobil Announces $2.5 Billion Accounting Write-Down in California | NASDAQ:ALVR | AlloVir Inc |
| 22/12/2023 | 13:00 | GlobeNewswire Inc. | AlloVir Provides Updates on Phase 3 Clinical Development Program for Posoleucel, an Allogeneic Virus-Specific T Cell Therapy | NASDAQ:ALVR | AlloVir Inc |
| 16/11/2023 | 13:00 | Business Wire | AlloVir to Present at the Piper Sandler 35th Annual Healthcare Conference | NASDAQ:ALVR | AlloVir Inc |
| 02/11/2023 | 12:00 | Business Wire | AlloVir Reports Third Quarter 2023 Financial Results | NASDAQ:ALVR | AlloVir Inc |
| 28/08/2023 | 13:00 | Business Wire | AlloVir to Present at Upcoming Investor Conferences | NASDAQ:ALVR | AlloVir Inc |
| 03/08/2023 | 13:00 | Business Wire | AlloVir Reports Second Quarter 2023 Financial Results | NASDAQ:ALVR | AlloVir Inc |
| 12/07/2023 | 13:41 | IH Market News | Wednesday’s Wall Street Highlights: Nvidia, VMware, Alphabet, Coty, IBM, and more | NASDAQ:ALVR | AlloVir Inc |
| 26/06/2023 | 22:14 | Edgar (US Regulatory) | Current Report Filing (8-k) | NASDAQ:ALVR | AlloVir Inc |
| 22/06/2023 | 23:16 | Edgar (US Regulatory) | Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) | NASDAQ:ALVR | AlloVir Inc |
| 22/06/2023 | 03:20 | Business Wire | AlloVir Announces Pricing of Public Offering of Common Stock | NASDAQ:ALVR | AlloVir Inc |
| 21/06/2023 | 23:01 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALVR | AlloVir Inc |
| 21/06/2023 | 22:18 | Business Wire | AlloVir Announces Proposed Public Offering of Common Stock | NASDAQ:ALVR | AlloVir Inc |